Nigeria

Resilience System


You are here

Vaccinations

Three doses of mRNA COVID vaccine show advantage against severe outcomes --study

A team led by US Food and Drug Administration (FDA) researchers studying Medicare claims data during the early Omicron SARS-CoV-2 variant months conclude that a third dose of mRNA COVID-19 vaccine provides significant protection against hospitalization and death compared with two doses but wanes substantially after 4 months.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. FDA authorizes sale of first home COVID/flu combo test outside of emergency use

As the country heads into the respiratory illness season, the US Food and Drug Administration (FDA) announced yesterday its marketing authorization of the first over-the-counter (OTC) rapid-antigen COVID-19/flu combination test outside of emergency use authorization.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Vaccinations
howdy folks
Page loaded in 0.742 seconds.